ArticleCancer management and research2022

Efficacy and Safety of Sintilimab in Combination with Concurrent Chemoradiotherapy for Locally Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (SHARED): Study Protocol of a Prospective, Multi-Center, Single-Arm Phase 2 Trial.

Jia Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.